Insider NameBuy/SellCompany NameTickerAmountShares Change
Aug 15, 2023Aug 17, 2023Meyer Colin John
Chief Innovation Officer
SellReata Pharmaceuticals IncRETA$169$463,052-3.25%
May 15, 2023May 17, 2023Meyer Colin John
Chief Innovation Officer
SellReata Pharmaceuticals IncRETA$84.56$527,063-7.37%
Mar 07, 2023Mar 08, 2023Meyer Colin John
Chief Innovation Officer
SellReata Pharmaceuticals IncRETA$84.57$52,518-0.73%
Mar 02, 2023Mar 06, 2023Meyer Colin John
Chief Innovation Officer
SellReata Pharmaceuticals IncRETA$86.72$8M-52.43%
Jun 14, 2021Jun 16, 2021Meyer Colin John
Chief Research Officer
SellReata Pharmaceuticals IncRETA$142.58$9M-77.92%
Nov 16, 2020Nov 18, 2020Meyer Colin John
Chief Research Officer
SellReata Pharmaceuticals IncRETA$169.57$4M-25.77%
Nov 09, 2020Nov 10, 2020Meyer Colin John
Chief Research Officer
SellReata Pharmaceuticals IncRETA$175$4M-25.77%
Aug 16, 2016Aug 17, 2016Meyer Colin John
Chief Medical Officer
BuyReata Pharmaceuticals IncRETA$16.26$113,820+20.48%
Jun 01, 2016Jun 02, 2016Meyer Colin JohnBuyReata Pharmaceuticals IncRETA$11$110,000+33.14%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.